1.Comparison of efficacy between sequential and concurrent chemoradiotherapy in treatment of advanced lung cancer and analysis of prognostic factors
Ying ZHANG ; Xu HE ; Tingli YIN
Journal of Clinical Medicine in Practice 2025;29(10):63-67,72
Objective To compare the efficacy of sequential chemoradiotherapy and concurrent chemoradiotherapy in treatment of advanced lung cancer and analyze influencing factors of prognosis.Methods Ninety-six patients with advanced lung cancer were selected as study subjects and random-ly divided into control group and observation group,with 48 patients in each group.The control group received sequential chemoradiotherapy,while the observation group received concurrent chemoradio-therapy.The levels of epidermal growth factor receptor(EGFR)and Karnofsky Performance Status(KPS)were compared between the two groups before and after treatment.Additionally,the short-term efficacy,progression-free survival(PFS),overall survival(OS),and 1-year survival rate were compared between the two groups.Based on prognostic survival,the patients were divided into surviv-al group(n=64)and death group(n=32).The Cox regression model was used to analyze the prog-nostic factors in patients with advanced lung cancer,and a receiver operating characteristic(ROC)curve was plotted to evaluate the predictive efficacy of combined indicators.Results The objective re-sponse rate and disease control rate in the observation group were 60.42%and 87.50%,respectively,which were significantly higher than 35.42%and 60.42%in the control group(P<0.05).After treatment,the EGFR level in the observation groupwas lower than that in the control group,while the KPS was higher(P<0.05).The PFS and OS in the observation group were longer than those in the control group,and the 1-year survival rate was higher(P<0.05).Significant differences were observed between the survival and death groups in terms of concurrent brain metastases,pre-treat-ment EGFR level,pre-treatment KPS,and treatment modality(P<0.05).Multivariate Cox regres-sion analysis revealed that concurrent brain metastases,pre-treatment EGFR level,and treatment-modality were independent prognostic factors for patients with advanced lung cancer(P<0.05).The ROC curve analysis showed that the area under the curve for the combination of concurrent brain metastases,pre-treatment EGFR level,and treatment modality in predicting the prognosis of patients with advanced lung cancer was 0.804,with a sensitivity of 0.688 and a specificity of 0.844.Conclusion Compared with sequential chemoradiotherapy,concurrent chemoradiotherapy is more effective in treatment of advanced lung cancer,thereby reducing EGFR levels,prolonging PFS and OS,and improving KPS and 1-year survival rate.Concurrent brain metastases,pre-treatment EGFR level,and treatment modality are independent prognostic factors,and their combination has a good predictive efficacy for prognosis.
2.Analysis of the relationship between stromal fibrosis degree and targeted therapy resistance and prognosis in EGFR mutant lung adenocarcinoma
Xiaoyue LI ; Na WANG ; Xianni LIU ; Tingli DAI ; Haiwen CHEN ; Jianguo XIN ; Wei WANG ; Menglan ZHANG
The Journal of Practical Medicine 2025;41(15):2381-2387
Objective To assess stromal fibrosis in epidermal growth factor receptor(EGFR)mutant lung adenocarcinoma and its association with resistance to targeted therapy and patient prognosis.Methods Medical records of 207 patients diagnosed with EGFR-mutant advanced lung adenocarcinoma who received treatment at a hospital between January 2021 and December 2022 were reviewed.A total of 86 patients were ultimately included based on their prognosis and survival duration.These patients were categorized into a resistance group(32 cases)and a non-resistance group(54 cases),depending on whether they developed resistance to targeted therapy within one year.Additionally,patients were classified into mild,moderate,and severe fibrosis groups according to the extent of fibrosis observed.Clinical and pathological characteristics,as well as fibrosis levels,were compared between the two groups.Factors influencing the development of resistance to targeted therapy in patients with EGFR-mutant lung adenocarcinoma were analyzed,and the survival outcomes of patients with varying degrees of fibrosis were evaluated during follow-up.Results In the resistance group,the prevalence of EGFR exon 20 insertion mutations,elevated CA125 levels,and the presence of moderate-to-severe fibrosis were significantly higher compared to the non-resistance group(P<0.05).Multivariate logistic regression analysis revealed that EGFR exon 20 inser-tion mutation(OR=3.691,95%CI:1.043~13.057),elevated CA125 levels(OR=4.104,95%CI:1.160~14.517),and moderate-to-severe fibrosis(OR=3.959,95%CI:1.410~11.115)were independent risk factors associated with resistance to targeted therapy among patients with EGFR-mutant lung adenocarcinoma(P<0.05).The Cox proportional hazards model demonstrated a C-index of 0.72(95%CI:0.65~0.79),with area under the curve(AUC)values for 1-year and 2-year survival predictions of 0.781 and 0.734,respectively.EGFR exon 20 insertion mutation(HR=3.691),moderate-to-severe fibrosis(HR=3.959),and elevated CA125 levels(HR=4.104)were identified as independent prognostic factors for overall survival in these patients following targeted therapy.The median progression-free survival(PFS)for patients with mild,moderate,and severe fibrosis was 10.5 months,7.2 months,and 3.9 months,respectively,while the median overall survival(OS)was 21.4 months,16.1 months,and 11.5 months,respectively.Statistically significant differences in both PFS and OS were observed across the three fibrosis severity groups.(P<0.05).Conclusion The extent of stromal fibrosis in EGFR-mutant lung adenocarcinoma influences resistance to targeted therapy,and the progression of fibrosis is correlated with an unfavorable prognosis.
3.Direct economic analysis of carbapenem-resistant gram-negative bacteria infections in southern Hainan region
Tingli SHI ; Chunyan ZHANG ; Rushou CHEN ; Xiefen LEI ; Lu WANG ; Haihua XU ; Xiangli CHEN ; Ting FU
Chinese Journal of Nosocomiology 2025;35(12):1871-1876
OBJECTIVE To analyze the direct economic burden associated with carbapenem-resistant gram-negative bacteria(CRGNB)infections during hospitalization,and to provide reference for relevant policy formulation.METHODS Basic information including ICU admission,International Classification of Diseases(ICD)codes and CRGNB infection of intensive care unit(ICU)inpatients from Sanya Central Hospital(the Third People's Hospi-tal of Hainan Province)in the southern Hainan region from 2019 to 2023 was collected for risk factor analysis.Propensity matching was performed between the CRGNB infection and non-infection subgroups,and the direct economic differences between the two groups were analyzed.RESULTS A total of 164 373 cases were includ-ed.Multifactor logistic regression analysis revealed that ICD codes F00-F99,G00-G99,I00-I99,J00-J99,L00-L99,N00-N99,P00-P96 and S00-T98,ICU admission,hospital-acquired infection,readmission within 90 days and hospitalization exceeding 7 days were risk factors for CRGNB infection,especially,codes J00-J99(respiratory system diseases)were 7.68 to 17.47 folds higer than codes C00-D48(tumors).In the direct economic analysis of CRGNB infection,different matching results yielded consistent findings.In the 1∶1 matching results,a compari-son of total hospitalization costs(yuan)between different groups showed that the infection group had higher total hospitalization costs than the non-infection group.The costs were as follows:CRGNB group(88 421.40 vs.32 475.56),subgroup with two or more CRGNB types(130 984.02 vs.47 367.27),group with CRGNB and oth-er multidrug-resistant bacteria(103 056.35 vs.37 724.78),CRAB group(98 486.01 vs.36 487.98),and CRE group(26 031.38 vs.17 621.82).CONCLUSIONS The direct economic burden of CRGNB infection is greater than that of the non-infection group.Among them,the direct economic burden of carbapenem-resistant gram-negative bacteria infection,carbapenem-resistant gram-negative bacteria co-infected with other multidrug-resistant bacteria and CRAB infection are the highest.
4.Abnormalities of cerebellar-cerebral circuits and social impairment in ASD
Wenjing HU ; Tingli HE ; Zhe ZHANG ; Hongyan XU ; Zhangying ZHOU ; Xinxin CUI ; Danmeng CHENG ; Yanan HAN ; Xianwen DONG ; Anqin DONG
Chinese Journal of Behavioral Medicine and Brain Science 2025;34(4):328-333
Autism spectrum disorder(ASD) is a neurodevelopmental disorder, and social impairment was one of the core symptoms of ASD, which can seriously affects the social life of patients.The pathogenesis of social impairment in ASD is unclear and it may involves many brain abnormalities.The related theories and hypotheses are numerous and there is no unified conclusion. Studies have shown that the cerebellum has extensive connections with brain networks and is involved in the regulation of social cognition, but its role in ASD has not been fully emphasized.The structural and functional abnormalities of the cerebellar-cortex (CC) loop in ASD patients can lead to language communication disorders, empathy disorders, difficulties in interpreting social cues, abnormal social reward processing and emotional regulation disorders, which are closely related to ASD social impairment. Noninvasive brain stimulation of the superficial cerebellum can improve the abnormal CC circuit in ASD patients, and the cerebellum can be considered as a target for the treatment of social disorders in ASD in the future.Based on the clinical and basic researches on social impairment in ASD in recent years, this article reviews the relevant manifestations of disorders which cerebellar and CC circuit involved, aiming to promote the development of related research in the future.
5.Direct economic analysis of carbapenem-resistant gram-negative bacteria infections in southern Hainan region
Tingli SHI ; Chunyan ZHANG ; Rushou CHEN ; Xiefen LEI ; Lu WANG ; Haihua XU ; Xiangli CHEN ; Ting FU
Chinese Journal of Nosocomiology 2025;35(12):1871-1876
OBJECTIVE To analyze the direct economic burden associated with carbapenem-resistant gram-negative bacteria(CRGNB)infections during hospitalization,and to provide reference for relevant policy formulation.METHODS Basic information including ICU admission,International Classification of Diseases(ICD)codes and CRGNB infection of intensive care unit(ICU)inpatients from Sanya Central Hospital(the Third People's Hospi-tal of Hainan Province)in the southern Hainan region from 2019 to 2023 was collected for risk factor analysis.Propensity matching was performed between the CRGNB infection and non-infection subgroups,and the direct economic differences between the two groups were analyzed.RESULTS A total of 164 373 cases were includ-ed.Multifactor logistic regression analysis revealed that ICD codes F00-F99,G00-G99,I00-I99,J00-J99,L00-L99,N00-N99,P00-P96 and S00-T98,ICU admission,hospital-acquired infection,readmission within 90 days and hospitalization exceeding 7 days were risk factors for CRGNB infection,especially,codes J00-J99(respiratory system diseases)were 7.68 to 17.47 folds higer than codes C00-D48(tumors).In the direct economic analysis of CRGNB infection,different matching results yielded consistent findings.In the 1∶1 matching results,a compari-son of total hospitalization costs(yuan)between different groups showed that the infection group had higher total hospitalization costs than the non-infection group.The costs were as follows:CRGNB group(88 421.40 vs.32 475.56),subgroup with two or more CRGNB types(130 984.02 vs.47 367.27),group with CRGNB and oth-er multidrug-resistant bacteria(103 056.35 vs.37 724.78),CRAB group(98 486.01 vs.36 487.98),and CRE group(26 031.38 vs.17 621.82).CONCLUSIONS The direct economic burden of CRGNB infection is greater than that of the non-infection group.Among them,the direct economic burden of carbapenem-resistant gram-negative bacteria infection,carbapenem-resistant gram-negative bacteria co-infected with other multidrug-resistant bacteria and CRAB infection are the highest.
6.Analysis of the relationship between stromal fibrosis degree and targeted therapy resistance and prognosis in EGFR mutant lung adenocarcinoma
Xiaoyue LI ; Na WANG ; Xianni LIU ; Tingli DAI ; Haiwen CHEN ; Jianguo XIN ; Wei WANG ; Menglan ZHANG
The Journal of Practical Medicine 2025;41(15):2381-2387
Objective To assess stromal fibrosis in epidermal growth factor receptor(EGFR)mutant lung adenocarcinoma and its association with resistance to targeted therapy and patient prognosis.Methods Medical records of 207 patients diagnosed with EGFR-mutant advanced lung adenocarcinoma who received treatment at a hospital between January 2021 and December 2022 were reviewed.A total of 86 patients were ultimately included based on their prognosis and survival duration.These patients were categorized into a resistance group(32 cases)and a non-resistance group(54 cases),depending on whether they developed resistance to targeted therapy within one year.Additionally,patients were classified into mild,moderate,and severe fibrosis groups according to the extent of fibrosis observed.Clinical and pathological characteristics,as well as fibrosis levels,were compared between the two groups.Factors influencing the development of resistance to targeted therapy in patients with EGFR-mutant lung adenocarcinoma were analyzed,and the survival outcomes of patients with varying degrees of fibrosis were evaluated during follow-up.Results In the resistance group,the prevalence of EGFR exon 20 insertion mutations,elevated CA125 levels,and the presence of moderate-to-severe fibrosis were significantly higher compared to the non-resistance group(P<0.05).Multivariate logistic regression analysis revealed that EGFR exon 20 inser-tion mutation(OR=3.691,95%CI:1.043~13.057),elevated CA125 levels(OR=4.104,95%CI:1.160~14.517),and moderate-to-severe fibrosis(OR=3.959,95%CI:1.410~11.115)were independent risk factors associated with resistance to targeted therapy among patients with EGFR-mutant lung adenocarcinoma(P<0.05).The Cox proportional hazards model demonstrated a C-index of 0.72(95%CI:0.65~0.79),with area under the curve(AUC)values for 1-year and 2-year survival predictions of 0.781 and 0.734,respectively.EGFR exon 20 insertion mutation(HR=3.691),moderate-to-severe fibrosis(HR=3.959),and elevated CA125 levels(HR=4.104)were identified as independent prognostic factors for overall survival in these patients following targeted therapy.The median progression-free survival(PFS)for patients with mild,moderate,and severe fibrosis was 10.5 months,7.2 months,and 3.9 months,respectively,while the median overall survival(OS)was 21.4 months,16.1 months,and 11.5 months,respectively.Statistically significant differences in both PFS and OS were observed across the three fibrosis severity groups.(P<0.05).Conclusion The extent of stromal fibrosis in EGFR-mutant lung adenocarcinoma influences resistance to targeted therapy,and the progression of fibrosis is correlated with an unfavorable prognosis.
7.Research progress on the involvement of abnormal temporal and spatial development of the striatum in repetitive and stereotyped behaviors in autism
Zhangying ZHOU ; Anqin DONG ; Hongyan XU ; Xinxin CUI ; Tingli HE ; Wenjing HU ; Zhe ZHANG ; Yanan HAN ; Danmeng CHENG ; Liguo LI ; Youcai TANG ; Xianwen DONG
Chinese Journal of Comparative Medicine 2025;35(6):167-176
As the incidence of autism rises annually,its unknown pathogenesis makes it challenging to treat the varied repetitive and stereotyped behaviors that characterize its core symptoms.The striatum is an important brain region for the control of locomotor behaviors,featuring a unique mosaic structure,complex neural origin,and finely regulated developmental process that is highly susceptible to genetic and environmental influences.Both clinical and basic studies have indicated that abnormal development of the striatal nuclei may contribute to the pathogenesis of these repetitive stereotyped behaviors in autism.Clinical imaging data have primarily identified gross anatomical variations in the stratum(e.g.,its general outline),but lack the resolution necessary to detect the cellular and subcellular alterations within the region.By introducing the abnormalities in the spatiotemporal development of the striatum and their links to the characteristic behaviors of autism,this review aims to advance our understanding of the role of the striatum in autism pathogenesis and to inform future animal studies and clinical research.
8.Abnormalities of cerebellar-cerebral circuits and social impairment in ASD
Wenjing HU ; Tingli HE ; Zhe ZHANG ; Hongyan XU ; Zhangying ZHOU ; Xinxin CUI ; Danmeng CHENG ; Yanan HAN ; Xianwen DONG ; Anqin DONG
Chinese Journal of Behavioral Medicine and Brain Science 2025;34(4):328-333
Autism spectrum disorder(ASD) is a neurodevelopmental disorder, and social impairment was one of the core symptoms of ASD, which can seriously affects the social life of patients.The pathogenesis of social impairment in ASD is unclear and it may involves many brain abnormalities.The related theories and hypotheses are numerous and there is no unified conclusion. Studies have shown that the cerebellum has extensive connections with brain networks and is involved in the regulation of social cognition, but its role in ASD has not been fully emphasized.The structural and functional abnormalities of the cerebellar-cortex (CC) loop in ASD patients can lead to language communication disorders, empathy disorders, difficulties in interpreting social cues, abnormal social reward processing and emotional regulation disorders, which are closely related to ASD social impairment. Noninvasive brain stimulation of the superficial cerebellum can improve the abnormal CC circuit in ASD patients, and the cerebellum can be considered as a target for the treatment of social disorders in ASD in the future.Based on the clinical and basic researches on social impairment in ASD in recent years, this article reviews the relevant manifestations of disorders which cerebellar and CC circuit involved, aiming to promote the development of related research in the future.
9.Research progress on the involvement of abnormal temporal and spatial development of the striatum in repetitive and stereotyped behaviors in autism
Zhangying ZHOU ; Anqin DONG ; Hongyan XU ; Xinxin CUI ; Tingli HE ; Wenjing HU ; Zhe ZHANG ; Yanan HAN ; Danmeng CHENG ; Liguo LI ; Youcai TANG ; Xianwen DONG
Chinese Journal of Comparative Medicine 2025;35(6):167-176
As the incidence of autism rises annually,its unknown pathogenesis makes it challenging to treat the varied repetitive and stereotyped behaviors that characterize its core symptoms.The striatum is an important brain region for the control of locomotor behaviors,featuring a unique mosaic structure,complex neural origin,and finely regulated developmental process that is highly susceptible to genetic and environmental influences.Both clinical and basic studies have indicated that abnormal development of the striatal nuclei may contribute to the pathogenesis of these repetitive stereotyped behaviors in autism.Clinical imaging data have primarily identified gross anatomical variations in the stratum(e.g.,its general outline),but lack the resolution necessary to detect the cellular and subcellular alterations within the region.By introducing the abnormalities in the spatiotemporal development of the striatum and their links to the characteristic behaviors of autism,this review aims to advance our understanding of the role of the striatum in autism pathogenesis and to inform future animal studies and clinical research.
10.Recent advance and challenge in clinical diagnosis and management of restricted repetitive behaviors in autism
Hongyan XU ; Xinxin CUI ; Zhangying ZHOU ; Wenjing HU ; Tingli HE ; Zhe ZHANG ; Danmeng CHENG ; Xianwen DONG ; Yanan HAN
Chinese Journal of Neuromedicine 2024;23(6):624-630
Restricted repetitive behaviors (RRBs) are the most characteristic behaviors of autism spectrum disorder. The clinical diagnosis and treatment of RRBs are extremely difficult resulting from its complex and variable etiology, highly heterogeneous clinical manifestations influenced by multiple factors (sleep quality, gastrointestinal health, age and gender), lack of precise diagnostic criteria and low effectiveness of current clinical interventions. This article mainly reviews the recent related studies on RRBs and discusses the challenges and progress in clinical diagnosis and treatment of RRBs so as to provide new ideas for future clinical diagnosis and treatment.

Result Analysis
Print
Save
E-mail